Comparison of 99mTc-UBI 29-41, 99mTc-ciprofloxacin, 99mTc-ciprofloxacin dithiocarbamate and 111In-biotin for targeting experimental Staphylococcus aureus and Escherichia coli foreign-body infections: an ex-vivo study
- 1 February 2019
- journal article
- research article
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 63 (1), 37-47
- https://doi.org/10.23736/S1824-4785.17.02975-2
Abstract
BACKGROUND: Diagnosis of implant-associated infection is challenging. Several radiopharmaceuticals have been described but direct comparisons are limited. Here we compared in vitro and in an animal model Tc-99m-IJIBI, Tc-99m-cipmfloxacin, (TcN)-Tc-99m-CipmCS(2) and In-111-DTPA-biotin for targeting E. coli (ATCC 25922) and S. aureus (ATCC 43335). METHODS: Stability controls were performed with the labelled radiopharmaceuticals during 6 hours in saline and serum. The in vitro binding to viable or killed bacteria was evaluated at 37 degrees C and 4 degrees C. For in vivo studies, Teflon cages were subcutaneously implanted in mice, followed by percutaneous infection. Biodistribution of i.v. injected radiolabelled radiopharmaceuticals were evaluated during 24 h in cages and dissected tissues. RESULTS: Labelling efficiency of all radiopharmaceuticals ranged between 94% and 98%, with high stability both in saline and in human serum. In vitro binding assays displayed a rapid but poor bacterial binding for all tested agents. Similar binding kinetic occurred also with heat-killed and ethanol-killed bacteria. In the tissue cage model, infection was detected at different time points: Tc-99m-UBI and (TcN)-Tc-99m-CiproCS(2) shoved higher infected cage/sterile cage ratio at 24 hours for both E. coli and S. aureus; Tc-99m-Ciprofloxacin at 24 hours for both E. coli and at 4 hours for S. aureus; In-111-DTPA-biotin accumulates faster in both E. coli and S. aureus infected cages. CONCLUSIONS: Tc-99m-UBI, (TeN)-Te-99m-CiproCS(2) showed poor in vitro binding but good in vivo binding to E. coli only. In-111-DTPA-biotin showed poor in vitro binding but good in vivo binding to S. aureus and poor to E. coli. Tc-99m-Ciprofloxacin showed poor in vitro binding but good in vivo binding to all tested bacteria. The mechanism of accumulation in infected sites remains to be elucidated.Keywords
This publication has 30 references indexed in Scilit:
- Detection of sites of infection in mice using 99mTc-labeled PN2S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution studyNuclear Medicine and Biology, 2009
- Nuclear Medicine and the Infected Joint ReplacementSeminars in Nuclear Medicine, 2009
- Diagnostic imaging tests and microbial infectionsCellular Microbiology, 2007
- Use of 99mTc-Sulesomab for the Diagnosis of Prosthesis Infection after Total Joint ArthroplastyJournal of International Medical Research, 2007
- Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental Staphylococcus aureus prosthetic joint infectionsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Kit for instant 99mTc labeling of the antimicrobial peptide ubiquicidin 29-41Journal of Radioanalytical and Nuclear Chemistry, 2005
- Prosthetic-Joint InfectionsThe New England Journal of Medicine, 2004
- Evaluation of technetium-99m-ciprofloxacin (Infecton) for detecting sites of inflammation in arthritisRheumatology, 2003
- Advances in the laboratory diagnosis of prosthetic joint infectionReviews in Medical Microbiology, 2003
- Imaging bacterial infection with 99mTc-ciprofloxacin (Infecton)Journal of Clinical Pathology, 2002